The 6 analysts offering 12-month price forecasts for Theratechnologies Inc have a median target of 7.50, with a high estimate of 36.00 and a low estimate of 1.46. The median estimate represents a +338.60% increase from the last price of 1.71.
The current consensus among 6 polled investment analysts is to Buy stock in Theratechnologies Inc. This rating has held steady since January, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.07
Reporting Date Sep 26
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.